RNA - Avidity Biosciences Inc
IEX Last Trade
43.93
1.290 2.936%
Share volume: 1,094,696
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$42.64
1.29
3.03%
Summary score
24%
Profitability
25%
Dept financing
3%
Liquidity
75%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-9.67%
Return on assets
-9.04%
Return on sales
-1943.15%
Return on invested capital
179.3%
Total debt ratio
10.77%
Debt ratio change over timeo
-0.93%
Current Ratio
13.22%
Quick Ratio
13.22%
Cash Position Ratio
12.95%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-9.72%
Return on assets
-9.39%
Return on sales
-2393.76%
Return on invested capital
136.24%
Total debt ratio
12.79%
Debt ratio change over timeo
-0.9%
Current Ratio
11.15%
Quick Ratio
11.15%
Cash Position Ratio
10.87%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-8.29%
Return on assets
-8.11%
Return on sales
-2178.58%
Return on invested capital
118.81%
Total debt ratio
12.67%
Debt ratio change over time
-0.87%
Current Ratio
12.47%
Quick Ratio
12.47%
Cash Position Ratio
12.22%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-105.96%
Return on assets
-105.58%
Return on sales
-1327.56%
Return on invested capital
3.5%
Total debt ratio
-93.11%
Debt ratio change over time
-0.93%
Current Ratio
6.74%
Quick Ratio
6.74%
Cash Position Ratio
6.58%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | RNA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -9.67% | 13.79% | 34.47% | 7.43% |
| Return on assets | -9.04% | 2.76% | 3.15% | 5.62% |
| Return on sales | -1943.15% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 179.3% | 2.36% | 5.39% | 19.77% |
| Profitability | 25% | 40% | 60% | 58% |
| Total debt ratio | 10.77% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -0.93% | 308.97% | -6.99% | 1.18% |
| Dept financing | 3% | 50% | 25% | 7% |
| Current Ratio | 11.15% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 11.15% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 10.87% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 4% | 8% | 19% |
| Short-term ratios | RNA | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -9.72% | 13.77% | 13.25% | 3.8% |
| Return on assets | -9.39% | 2.43% | 1.89% | 3.09% |
| Return on sales | -2393.76% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 136.24% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 65% | 59% | 59% |
| Total debt ratio | 12.79% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -0.9% | 46.38% | -72.08% | 1.51% |
| Dept financing | 3% | 50% | 25% | 7% |
| Current Ratio | 11.15% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 11.15% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 10.87% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 5% | 12% | 29% |